Pixel by LabCorp has been granted an Emergency Use Authorization (EUA) by the FDA, which makes it the first COVID-19 at-home test kit to receive FDA approval. The company says that it will initially make Pixel available to health workers and first responders but they are working hard to make the kits available for consumers in the coming weeks. Consumers may already sign up to receive an email notification when it becomes publicly available.
“LabCorp continues to develop new ways to help patients and healthcare providers fight the COVID-19 crisis through our leading testing capabilities and deep scientific and research expertise. Our at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time,” LabCorp president and CEO Adam Schechter said in a statement.
LabCorp will first screen users for eligibility to purchase and use the test kit through an eligibility survey in its website. If eligible, Pixel will be delivered to the user’s home after payment and users must follow the included instructions, collect their own sample, and use the provided prepaid packaging to send the obtained sample for processing. LabCorp labs will then analyze the sample and notify users via email when their results are available online.